Clinical Trials Logo

Filter by:
NCT ID: NCT01828073 Completed - HIV Infections Clinical Trials

Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants

Start date: May 19, 2011
Phase:
Study type: Observational

The purpose of this study was to determine the washout pharmacokinetics (PK) and safety of in utero/intrapartum exposure to maternal raltegravir (RAL) in infants born to pregnant women with HIV infection who received RAL 400 mg twice daily. The study also provided data for the development of an infant RAL starting dosing regimen for IMPAACT P1110 (NCT01780831).

NCT ID: NCT01827176 Completed - Clinical trials for Acute Recurrent Sinusitis

Clinical Characteristic of Recurrent Acute Rhinosinusitis in Children

Start date: March 2013
Phase: N/A
Study type: Observational

The purpose of this study is to determine the clinical characteristic of recurrent acute rhinosinusitis in children.

NCT ID: NCT01819038 Completed - Acute Renal Failure Clinical Trials

Early Renal Replacement Therapy and the Outcome of Acute Kidney Injury

EarlyRRT
Start date: January 2013
Phase: N/A
Study type: Interventional

This research project is a prospective study to compare mortality between early renal replacement therapy (RRT) and late renal replacement therapy by using plasma neutrophil gelatinase associated lipocalin (pNGAL) as a tool in decision- making.

NCT ID: NCT01818596 Completed - HIV Infections Clinical Trials

Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

Start date: March 27, 2013
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to evaluate the effect of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) fixed-dose combination (FDC) tablet on renal parameters at Week 24 in treatment-naive and treatment-experienced HIV-positive, adults with mild to moderate renal impairment.

NCT ID: NCT01816243 Completed - Chronic Pain Clinical Trials

An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Thai Participants With Chronic Non-Malignant Pain

Start date: April 2004
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of Transdermal Therapeutic System (TTS)-fentanyl patch (transdermal patch containing a drug that is put on the skin so the drug will enter the body through the skin) in Thai participants with chronic (lasting a long time) non-malignant (non-cancerous) pain.

NCT ID: NCT01815736 Completed - HIV Infections Clinical Trials

Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants

Start date: March 27, 2013
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to evaluate the non-inferiority of switching to a tenofovir alafenamide (TAF)-containing fixed dose combination (FDC) relative to maintaining tenofovir disoproxil fumarate (TDF)-containing combination regimens in virologically suppressed HIV-infected participants as determined by having HIV-1 RNA < 50 copies/mL at Week 48.

NCT ID: NCT01815255 Completed - Clinical trials for HIV-infected Thai Children

TDF Long Term Study

Start date: December 2010
Phase:
Study type: Observational

This study will assess the safety and efficacy of generic TDF from Governmental Pharmaceutical Organization (GPO) in HIV-infected children

NCT ID: NCT01814306 Enrolling by invitation - Clinical trials for Inadequate or Impaired Breathing Pattern or Ventilation

Supreme LMA and Proseal LMA in Prone Anesthetized Patient

SPLMA
Start date: October 2011
Phase: N/A
Study type: Interventional

There is no significant difference about success rate of two devices.

NCT ID: NCT01813175 Completed - Clinical trials for Beneficial Bacteria in Gut

Color Synbiotics Study

Start date: May 2013
Phase: N/A
Study type: Interventional

This study is initiated to investigate the effect of infant formula with added specific synbiotics mixture on proportion of beneficial bacteria.

NCT ID: NCT01806831 Completed - Skin Irritation Clinical Trials

Efficacy and Safety of Biocellulose Sheet Containing Anti-hyperpigmentation Agent ("Biocellulose Mask", "Farhorm®") in Patients Receiving Laser Treatment

Start date: September 2012
Phase: N/A
Study type: Interventional

The laser areas treated with biocellulose sheet from coconut juice containing anti-hyperpigmentation agent ("biocellulose mask", "Farhorm®") heal faster than vaseline ointment which is a standard treatment.